Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Checklist for the distribution of patients into risk groups for metabolically associated fatty liver disease: features of use in the hospital admissions department

DOI: https://doi.org/10.29296/25879979-2023-04-04
Issue: 
4
Year: 
2023

A.V. Borsukov(1), D.Yu. Venidiktova(1), S.A. Borsukov(2), P.A. Ivanov(1),
I.V. Petuhov3
1-Smolensk State Medical University, the Ministry of Health of the Russian Federation, Fundamental research laboratory “Diagnostic researches and minimally invasive technologies”. Krupskoy street 28, Smolensk, Russia, 214019
2-Clinical City Hospital No. 1, department of diagnostic and minimally invasive technologies. Frunze street 40, Smolensk, Russia, 214006.
3-Clinical Emergency Hospital. Tenisheva street, Smolensk, Russia, 214000.

Relevance: due to the widespread prevalence of obesity, metabolic syndrome and associated fatty liver disease, as well as due to the lack of an integrated approach to diagnosing the components of metabolically associated fatty liver disease, it is necessary to search for the possibility of early diagnosis already at the level of the admission department of a multidisciplinary hospital. Objective: to evaluate the effectiveness of the checklist used in the distribution of patients into risk groups for metabolically associated fatty liver disease in tne hospital admissions department. Materials and methods: in 2019 - 2022 the study was conducted of patients with overweight or obesity (n=74) according to anthropometric data, admitted for treatment to a multidisciplinary hospital in the following profiles: gastroenterology, cardiology, surgery, pulmonology, of which 41 women (55.4%), 33 men (44.6%), mean age 42±4.2 years. For the distribution of patients into groups, taking into account the risk factor for the occurrence of metabolically associated fatty liver disease, a checklist developed for this study with a score and quantitative ultrasound steatometry of the liver was used. Results and Discussion: correlation of quantitative ultrasound steatometry data with a comprehensive assessment of the presence of metabolic syndrome according to the checklist corresponds to r=0.85 (in the 1st group of patients); r=0.76 (in the 2nd group of patients); r=0.89 (in the 3rd group patients). In the control group 1, patients of the admission department with normal body weight (number of points according to the checklist no more than 2) were examined - liver steatosis without signs of inflammatory activity and liver fibrosis was detected in 7 patients (15.9%). Conclusions: the use of a checklist by paramedical staff for assigning patients to risk groups for metabolically associated fatty liver disease can reduce the time to detect the disease at an early stage, as well as reduce the time to detect the disease at an early stage, as well as reduce excessive unreasonable workload on ultrasound and radiation diagnostics units.
Keywords: 
checklist
obesity
emergency room
liver ultrasound
liver steatosis
nursing practice.

References: 
  1. Винницкая Е. В., Сандлер Ю. Г., Бордин Д. С. Новая парадигма неалкогольной жировой болезни печени: фенотипическое многообразие метаболически ассоциированной жировой болезни печени. Эффективная фармакотерапия. 2020; 16(24): 54–63. DOI 10.33978/2307-3586-2020-16-24-54-63. – EDN SFYLEN.
  2. Биек А. Ю., Саитов А. Р., Добрынина И. Ю. и др. Метаболически ассоциированная неалкогольная жировая болезнь печени. Вестник СурГУ. Медицина. 2021. 49(3): 14–19. DOI 10.34822/2304-9448-2021-3-14-19. – EDN HRTQOM.
  3. Nolan P. B., Carrick-Ranson G., Stinear J. W. et al. Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis. Отчеты по профилактической медицине. 2017; 7: 211–215. DOI 10.1016/j.pmedr.2017.07.004. – EDN YGWMRR.
  4. Вильсон И., Беленькая Л. В., Шолохов Л. Ф. и др. Метаболический синдром: эпидемиология, критерии диагностики, расовые особенности. Acta Biomedica Scientifica (East Siberian Biomedical Journal). 2021; 6(4): 180–191. DOI 10.29413/ABS.2021-6.4.16. – EDN AZSJDE.
  5. Венидиктова Д. Ю., Горбатенко О. А., Ковалев А. А. и др. Лучевая диагностика метаболического синдрома у пациентов мужского пола с неалкогольной жировой болезнью печени. Смоленский медицинский альманах. 2020; 1: 63–66. EDN LCHHGP.
  6. Драпкина О. М., Корнеева О. Н. Континуум неалкогольной жировой болезни печени: от стеатоза печени до сердечно-сосудистого риска. Рациональная фармакотерапия в кардиологии. 2016; 12(4): 424–429. DOI 10.20996/1819-6446-2016-12-4-424-429. – EDN WMHLON.
  7. Хорлампенко А. А., Каретникова В. Н., Кочергина А. М. и др. Индекс висцерального ожирения у пациентов с ишемической болезнью сердца, ожирением и сахарным диабетом 2 типа. Кардиоваскулярная терапия и профилактика. 2020; 19(3): 172–180. DOI 10.15829/1728-8800-2020-2311. – EDN WKXBSO.
  8. Лазебник Л. Б., Голованова Е. В., Туркина С. В. и др. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия. Экспериментальная и клиническая гастроэнтерология. 2021;185(1): 4–52. DOI: 10.31146/1682-8658-ecg-185-1-4-52.